HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Carmela Fimognari Selected Research
Carmela Fimognari Research Topics
Disease
65
Neoplasms (Cancer)
03/2024 - 04/2002
14
Leukemia
01/2023 - 04/2002
5
Inflammation (Inflammations)
01/2021 - 04/2012
4
Carcinogenesis
09/2022 - 04/2002
4
Necrosis
01/2017 - 04/2002
3
Breast Neoplasms (Breast Cancer)
11/2021 - 10/2006
2
Colorectal Neoplasms (Colorectal Cancer)
03/2024 - 01/2017
2
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
10/2022 - 01/2014
2
Chronic Disease (Chronic Diseases)
01/2022 - 01/2012
2
COVID-19
07/2021 - 01/2020
2
Neoplasm Metastasis (Metastasis)
06/2021 - 05/2007
2
Cardiovascular Diseases (Cardiovascular Disease)
01/2019 - 04/2012
2
Prostatic Neoplasms (Prostate Cancer)
01/2019 - 01/2015
2
Alzheimer Disease (Alzheimer's Disease)
08/2018 - 11/2009
2
Neurodegenerative Diseases (Neurodegenerative Disease)
08/2018 - 11/2009
1
Obesity
11/2023
1
Hypertension (High Blood Pressure)
11/2023
1
Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2023
1
Head and Neck Neoplasms (Head and Neck Cancer)
12/2022
1
Squamous Cell Carcinoma of Head and Neck
12/2022
1
Thrombosis (Thrombus)
07/2021
1
Rheumatoid Arthritis
07/2021
1
Primary Myelofibrosis (Myelosclerosis)
07/2021
1
Infections
07/2021
1
Rupture
06/2021
1
Colonic Neoplasms (Colon Cancer)
06/2021
1
Lymphoma (Lymphomas)
01/2021
1
Glioma (Gliomas)
01/2021
Drug/Important Bio-Agent (IBA)
12
sulforaphane
IBA
12/2021 - 04/2002
8
Enzymes
IBA
01/2022 - 04/2002
8
Carcinogens
IBA
11/2021 - 04/2002
8
Phytochemicals
IBA
01/2021 - 01/2014
6
isothiocyanic acid
IBA
02/2015 - 04/2002
5
Antioxidants
IBA
01/2022 - 10/2005
5
DNA (Deoxyribonucleic Acid)
IBA
10/2017 - 05/2007
4
Proteins (Proteins, Gene)
FDA Link
10/2022 - 01/2011
4
RNA (Ribonucleic Acid)
IBA
01/2015 - 11/2009
4
Isothiocyanates
IBA
04/2012 - 12/2003
3
Type II DNA Topoisomerases (Topoisomerase II)
IBA
10/2022 - 03/2017
3
Antineoplastic Agents (Antineoplastics)
IBA
09/2022 - 04/2004
3
Smoke
IBA
01/2022 - 11/2019
2
1-phenyl-3,3-dimethyltriazene (PDT)
IBA
03/2024 - 12/2022
2
Peptides (Polypeptides)
IBA
03/2023 - 08/2018
2
Polyketides
IBA
03/2023 - 12/2022
2
temoporfin
IBA
03/2023 - 12/2022
2
Doxorubicin (Adriamycin)
FDA Link
Generic
01/2023 - 10/2006
2
Phospholipid Hydroperoxide Glutathione Peroxidase
IBA
10/2022 - 11/2020
2
Glutathione (Reduced Glutathione)
IBA
10/2022 - 01/2020
2
Aerosols
IBA
01/2022 - 11/2019
2
Aromatase (CYP19)
IBA
11/2021 - 01/2019
2
Estrogen Receptors
IBA
11/2021 - 01/2019
2
Oxygen (Dioxygen)
IBA
07/2021 - 01/2019
2
HMGB1 Protein (HMG1)
IBA
11/2020 - 05/2018
2
Adenosine Triphosphate (ATP)
IBA
11/2020 - 05/2018
2
Proteasome Endopeptidase Complex (Proteasome)
IBA
10/2019 - 12/2015
2
Reactive Oxygen Species (Oxygen Radicals)
IBA
08/2018 - 07/2010
2
Sulfur
IBA
01/2015 - 04/2009
2
cyanidin-3-O-beta-glucopyranoside
IBA
10/2005 - 06/2004
2
bcl-2-Associated X Protein (bcl 2 Associated X Protein)
IBA
12/2003 - 04/2002
1
Lipids
IBA
11/2023
1
Antihypertensive Agents (Antihypertensives)
IBA
11/2023
1
Hypoglycemic Agents (Hypoglycemics)
IBA
11/2023
1
fucoidan
IBA
05/2023
1
Polysaccharides (Glycans)
IBA
05/2023
1
Carrier Proteins (Binding Protein)
IBA
03/2023
1
plocabulin
IBA
12/2022
1
Human Serum Albumin
FDA Link
Generic
12/2022
1
Solutions
IBA
12/2022
1
Photosensitizing Agents (Photosensitizers)
IBA
12/2022
1
perillaldehyde
IBA
10/2022
1
Nexus
IBA
09/2022
1
Sulfur Compounds (Compounds, Sulfur)
IBA
01/2022
1
allicin
IBA
01/2022
1
Biomarkers (Surrogate Marker)
IBA
01/2022
1
mesoglycan
IBA
01/2022
1
Estrogens (Estrogen)
FDA Link
11/2021
1
Mitogen-Activated Protein Kinases
IBA
11/2021
1
Oxindoles
IBA
10/2021
1
Janus Kinases
IBA
07/2021
1
Janus Kinase Inhibitors
IBA
07/2021
1
ruxolitinib
IBA
07/2021
1
baricitinib
IBA
07/2021
1
remdesivir
IBA
07/2021
1
Gold
IBA
06/2021
1
Coffee
FDA Link
01/2021
1
Free Radicals
IBA
01/2021
1
piperine
IBA
11/2020
1
Iron
IBA
11/2020
Therapy/Procedure
21
Therapeutics
11/2022 - 04/2004
6
Chemoprevention
01/2021 - 12/2003
6
Drug Therapy (Chemotherapy)
01/2020 - 10/2006
2
Immunotherapy
11/2020 - 05/2018
1
Photochemotherapy (Photodynamic Therapy)
03/2024
1
Resistance Training
01/2022
1
Artificial Respiration (Mechanical Ventilation)
07/2021
1
Extracorporeal Membrane Oxygenation
07/2021
1
Oral Administration
07/2021
1
Induced Hyperthermia (Thermotherapy)
06/2021
1
Lasers (Laser)
06/2021
1
Photothermal Therapy
06/2021